Detailed Narrative
Q4 & FY25 Performance Overview
S H Kelkar & Co. reported a strong 15% revenue growth for the fiscal year FY25, driven by sustained demand across all segments. The domestic market showed particularly healthy traction. The Fragrance division achieved a 19% growth, while the Flavour division recorded a robust 43% growth on a subdued base from the previous year. This performance was supported by increased engagement with small and mid-clients, alongside contributions from global MNC accounts.
Margin Outlook and Cost Management
Gross margins were impacted in the second half of FY25 due to supply-side constraints and elevated input costs. To mitigate this, the company has implemented price increases averaging 3% to 3.5%, with benefits expected to reflect gradually in coming quarters. The FY25 EBITDA margin was around 15%, and it is expected to remain in this range for FY26 due to Rs. 15-20 crore in additional operational costs. However, management anticipates a recovery to 18-20% EBITDA margins from FY27 onwards, once new factory operations resume.
Strategic Growth Initiatives and New Geographies
The company is focused on leveraging multiple growth drivers, including ramping up its CDCs in Germany and UK, and upcoming investments in Manchester and New Jersey. These new overseas centers are projected to contribute Rs. 250-300 crore in revenue over the next three to four years, with Germany already operational and generating traction. This expansion into new geographies is a key part of the strategy for future sustainable growth.
Global Ingredients Business and China+1 Strategy
The Ingredient segment continued to make steady progress, generating around Rs. 70 crore in FY25. The company sees significant emerging opportunities driven by the 'China plus One' shift and rising demand in European markets. SHK's strategy in this segment focuses on niche areas where it has unique capabilities in chemistry, avoiding highly competitive, low-margin, and high-CAPEX segments. This approach aims to capitalize on demand for alternate suppliers without diluting margins.
Capex and Debt Management
S H Kelkar & Co. plans a Capex of approximately Rs. 200 crore over the next two years. This includes an investment of €6-7 million (Rs. 60-70 crore) for a new facility in Europe to address current capacity constraints. The company's net debt currently stands at Rs. 658 crore, but it is targeted to reduce to Rs. 550 +/- Rs. 20 crore by the end of FY26, supported by internal accruals and expected insurance payouts. From FY27, a substantial reduction in debt is anticipated.
Vashivali and Vanavate Facilities Update
The re-establishment of the Vashivali Fragrance facility is progressing well and is expected to be commissioned within the current financial year. This facility was fully insured, and an interim payment of Rs. 95 crore has been received as part of the fire-related claims settlement. Additionally, the upcoming Greenfield facility at Vanavate is advancing as planned and is slated for commissioning later this calendar year. These sites are expected to build operational synergies and improve inventory management.